Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Lind

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Current Opinion in Oncology|December 1, 1989
Alkylating agentsM J Lind, N Thatcher
Cancer Surveys|January 1, 1993
Pharmacokinetics of alkylating agentsM J Lind, C Ardiet
European Journal of Cancer (Oxford, England : 1990)|June 21, 2005
Cyclooxygenase-2 expression predicts survival in malignant pleural mesotheliomaS L O'Kane, L Cawkwell, A Campbell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
The effect of route of administration and fractionation of dose on the metabolism of ifosfamideM J Lind, H L Roberts, N Thatcher, et al.
Lancet (London, England)|October 20, 1990
21-day cycles of oral etoposide in heavily pretreated metastatic germ-cell cancerB M Cantwell, M J Millward, M J Lind, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Metastatic breast cancer presenting with diabetes insipidusL C Tham, M J Millward, M J Lind, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Ifosfamide metabolism and DNA damage in tumour and peripheral blood lymphocytes of breast cancer patientsE C Johnstone, M J Lind, M J Griffin, et al.
Cancer Research|February 1, 1989
Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinomaM J Lind, J M Margison, T Cerny, et al.
British Journal of Clinical Pharmacology|July 1, 1990
The effect of age on the pharmacokinetics of ifosfamideM J Lind, J M Margison, T Cerny, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Pharmacokinetics, metabolism and clinical effect of ifosfamide in breast cancer patientsA V Boddy, M Proctor, D Simmonds, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Current Opinion in Oncology|December 1, 1989
Alkylating agentsM J Lind, N Thatcher
Cancer Surveys|January 1, 1993
Pharmacokinetics of alkylating agentsM J Lind, C Ardiet
European Journal of Cancer (Oxford, England : 1990)|June 21, 2005
Cyclooxygenase-2 expression predicts survival in malignant pleural mesotheliomaS L O'Kane, L Cawkwell, A Campbell, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
The effect of route of administration and fractionation of dose on the metabolism of ifosfamideM J Lind, H L Roberts, N Thatcher, et al.
Lancet (London, England)|October 20, 1990
21-day cycles of oral etoposide in heavily pretreated metastatic germ-cell cancerB M Cantwell, M J Millward, M J Lind, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Metastatic breast cancer presenting with diabetes insipidusL C Tham, M J Millward, M J Lind, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2001
Ifosfamide metabolism and DNA damage in tumour and peripheral blood lymphocytes of breast cancer patientsE C Johnstone, M J Lind, M J Griffin, et al.
Cancer Research|February 1, 1989
Comparative pharmacokinetics and alkylating activity of fractionated intravenous and oral ifosfamide in patients with bronchogenic carcinomaM J Lind, J M Margison, T Cerny, et al.
British Journal of Clinical Pharmacology|July 1, 1990
The effect of age on the pharmacokinetics of ifosfamideM J Lind, J M Margison, T Cerny, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Pharmacokinetics, metabolism and clinical effect of ifosfamide in breast cancer patientsA V Boddy, M Proctor, D Simmonds, et al.
Pageof 5